Brief: Protara Therapeutics Inc Continues To ExpecT Investments Of $90 Million To Fund Operations Into 2025
04/05/2023 13:09
May 4 (Reuters) - Protara Therapeutics Inc TARA.O :
* PROTARA THERAPEUTICS INC Q1 LOSS PER SHARE $0.80
* PROTARA THERAPEUTICS ANNOUNCES FIRST QUARTER 2023
FINANCIAL
RESULTS AND BUSINESS UPDATE
* PROTARA THERAPEUTICS INC SAYS CONTINUES TO EXPECT CASH,
CASH
EQUIVALENTS AND INVESTMENTS OF $90 MILLION AS OF MARCH 31, 2023
TO FUND OPERATIONS INTO 2025
Source text for Eikon: ID:nGNXc95P3Q
Further company coverage: TARA.O
Recent news on Protara Therapeutics
See all newsProtara Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Protara Therapeutics Q2 net loss widens on higher expenses
Brief: Protara Therapeutics - Enters Sales Agreement With TD Cowen For Common Stock Offering
Brief: Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses
Protara Therapeutics Q1 net loss widens on higher expenses